BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2023 Earnings Call Transcript April 26, 2023
BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.27, expectations were $0.18.
Operator: Welcome to the BioMarin Pharmaceuticals First Quarter Investor Update Call. Hosting the conference call today from BioMarin is Traci McCarty, Group Vice President, Investor Relations. Please go ahead, Traci.
Traci McCarty: Thank you, Ross, and thank you all for joining us today. To remind...
